Delivery of Water-Soluble Drugs Using Acoustically Triggered Perfluorocarbon Double Emulsions

ABSTRACTPurposeUltrasound can be used to release a therapeutic payload encapsulated within a perfluorocarbon (PFC) emulsion via acoustic droplet vaporization (ADV), a process whereby the PFC phase is vaporized and the agent is released. ADV-generated microbubbles have been previously used to selectively occlude blood vessels in vivo. The coupling of ADV-generated drug delivery and occlusion has therapeutically synergistic potentials.MethodsMicron-sized, water-in-PFC-in-water (W1/PFC/W2) emulsions were prepared in a two-step process using perfluoropentane (PFP) or perfluorohexane (PFH) as the PFC phase. Fluorescein or thrombin was contained in the W1 phase.ResultsDouble emulsions containing fluorescein in the W1 phase displayed a 5.7±1.4-fold and 8.2±1.3-fold increase in fluorescein mass flux, as measured using a Franz diffusion cell, after ADV for the PFP and PFH emulsions, respectively. Thrombin was stably retained in four out of five double emulsions. For three out of five formulations tested, the clotting time of whole blood decreased, in a statistically significant manner (p < 0.01), when incubated with thrombin-loaded emulsions exposed to ultrasound compared to emulsions not exposed to ultrasound.ConclusionsADV can be used to spatially and temporally control the delivery of water-soluble compounds formulated in PFC double emulsions. Thrombin release could extend the duration of ADV-generated, microbubble occlusions.

[1]  Wen-Zhi Chen,et al.  Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. , 2005, Radiology.

[2]  Helen Song,et al.  Controlling nonspecific protein adsorption in a plug-based microfluidic system by controlling interfacial chemistry using fluorous-phase surfactants. , 2005, Analytical chemistry.

[3]  S. Borgne,et al.  Amidase activity and thermal stability of human thrombin , 1994, Applied biochemistry and biotechnology.

[4]  M. Shimizu,et al.  Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. , 1999, The Journal of pharmacology and experimental therapeutics.

[5]  Feng-Yi Yang,et al.  Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption. , 2009, The Journal of the Acoustical Society of America.

[6]  Liu Xin,et al.  Rheological models for xanthan gum , 1996 .

[7]  Zhigang Wang,et al.  A novel ultrasound microbubble carrying gene and Tat peptide: preparation and characterization. , 2009, Academic radiology.

[8]  T. D. Mast,et al.  Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. , 2008, Ultrasound in medicine & biology.

[9]  Kullervo Hynynen,et al.  Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. , 2003, Ultrasound in medicine & biology.

[10]  J Jesty,et al.  The kinetics of inhibition of alpha-thrombin in human plasma. , 1986, The Journal of biological chemistry.

[11]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[12]  T. Vandamme,et al.  Reverse water-in-fluorocarbon emulsions and microemulsions obtained with a fluorinated surfactant , 2004 .

[13]  S. Umemura,et al.  Nanoparticles with Multiple Perfluorocarbons for Controllable Ultrasonically Induced Phase Shifting , 2005 .

[14]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Jonathan A. Kopechek,et al.  Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo , 2010, Journal of liposome research.

[16]  C. Hung,et al.  Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells. , 2009, Ultrasonics.

[17]  Paul A Dayton,et al.  Targeted imaging using ultrasound , 2002, Journal of magnetic resonance imaging : JMRI.

[18]  J. S. Johnson,et al.  Biocompatible surfactants for water-in-fluorocarbon emulsions. , 2008, Lab on a chip.

[19]  Chi-Feng Hung,et al.  A study of the formulation design of acoustically active lipospheres as carriers for drug delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  M. Dujovny,et al.  Embolization of the Nidus of Brain Arteriovenous Malformations with n-butyl Cyanoacrylate , 1997 .

[21]  D. Burgess,et al.  Multiple emulsion stability: pressure balance and interfacial film strength. , 2002, Journal of colloid and interface science.

[22]  H. Kikuchi,et al.  A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations , 1996, Neuroradiology.

[23]  S. Putney.  Encapsulation of proteins for improved delivery. , 1998, Current opinion in chemical biology.

[24]  A. Aserin,et al.  Recent Developments in O/W/O Multiple Emulsions , 2007 .

[25]  S M Moghimi,et al.  Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. , 2000, Trends in biotechnology.

[26]  Conrad Coester,et al.  Microbubbles as ultrasound triggered drug carriers. , 2009, Journal of pharmaceutical sciences.

[27]  A. Florence,et al.  The formulation and stability of multiple emulsions , 1982 .

[28]  K. Lowe,et al.  Pluronic F-68 inhibits agonist-induced platelet aggregation in human whole blood in vitro. , 1998, Artificial cells, blood substitutes, and immobilization biotechnology.

[29]  P. Carson,et al.  On the acoustic vaporization of micrometer-sized droplets. , 2004, The Journal of the Acoustical Society of America.

[30]  P. Carson,et al.  The role of inertial cavitation in acoustic droplet vaporization , 2008, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[31]  J B Fowlkes,et al.  Acoustic droplet vaporization for therapeutic and diagnostic applications. , 2000, Ultrasound in medicine & biology.

[32]  Jean G. Riess,et al.  Oxygen Carriers (“Blood Substitutes”)Raison d'Etre, Chemistry, and Some Physiology Blut ist ein ganz besondrer Saft1 , 2001 .

[33]  J. Riess,et al.  Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology. , 2001, Chemical reviews.

[34]  B. Müller,et al.  The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions , 1998 .

[35]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide , 1991 .

[36]  Stefaan C De Smedt,et al.  Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  S. Margel,et al.  Synthesis and Characterization of Thrombin Conjugated γ‐Fe2O3 Magnetic Nanoparticles for Hemostasis , 2009 .

[38]  M. Taghizadeh,et al.  Effect of molecular weight on the ultrasonic degradation of poly(vinyl-pyrrolidone). , 2009, Ultrasonics sonochemistry.

[39]  T. Hwang,et al.  Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. , 2009, Journal of pharmaceutical sciences.

[40]  C. Tonelli,et al.  Perfluoropolyether functional oligomers: unusual reactivity in organic chemistry , 2002 .

[41]  P. Carson,et al.  Initial investigation of acoustic droplet vaporization for occlusion in canine kidney. , 2010, Ultrasound in medicine & biology.

[42]  Alisa S Wolberg,et al.  Thrombin generation and fibrin clot structure. , 2007, Blood reviews.

[43]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[44]  S. Margel,et al.  Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. , 2010, Biomaterials.

[45]  R. Nelson,et al.  Treatment of iatrogenic femoral arterial pseudoaneurysms: comparison of US-guided thrombin injection with compression repair. , 2000, Radiology.

[46]  A. Congiu Castellano,et al.  Structural changes induced in proteins by therapeutic ultrasounds. , 2009, Ultrasonics.

[47]  M. Wheatley,et al.  Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[48]  J. Jesty.  Measurement of the kinetics of inhibition of activated coagulation factor X in human plasma: the effect of plasma and inhibitor concentration. , 1986, Analytical biochemistry.

[49]  N. Rapoport.  Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery , 2007 .

[50]  Susannah H Bloch,et al.  Application of Ultrasound to Selectively Localize Nanodroplets for Targeted Imaging and Therapy , 2006, Molecular imaging.

[51]  F. Terrier,et al.  Treatment of gastrointestinal hemorrhage , 2005, Abdominal Imaging.

[52]  P. Carson,et al.  Acoustic droplet vaporization for temporal and spatial control of tissue occlusion: a kidney study , 2005, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[53]  A. Petroianu.  Arterial Embolization for Hemorrhage Caused by Hepatic Arterial Injury , 2007, Digestive Diseases and Sciences.

[54]  T. J. Mcmanus,et al.  A cltrate-phosphatedextrose solution for the preservation of human blood. , 1957, American journal of clinical pathology.

[55]  A. Oliva,et al.  Effect of high shear rate on stability of proteins: kinetic study. , 2003, Journal of pharmaceutical and biomedical analysis.

[56]  Y. Kita,et al.  An attempt at preparing water-in-oil-in-water multiple-phase emulsions , 1976 .

[57]  Elias Fattal,et al.  Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and 19F-MRI , 2009, Pharmaceutical Research.

[58]  K. Mann,et al.  A review of the therapeutic uses of thrombin , 2004, Thrombosis and Haemostasis.

[59]  W. Bloomer,et al.  NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivo. , 1998, International journal of radiation oncology, biology, physics.

[60]  K. Lackner,et al.  Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients. , 2005, Radiology.

[61]  E. Unger,et al.  Therapeutic applications of lipid-coated microbubbles. , 2004, Advanced drug delivery reviews.

[62]  A. Aserin.  Multiple emulsions : technology and applications , 2008 .

[63]  M Halliwell,et al.  Sonoporation, drug delivery, and gene therapy , 2010, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[64]  Oliver D Kripfgans,et al.  Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion. , 2010, Ultrasound in medicine & biology.

[65]  T. Chandy,et al.  Development of polylactide microspheres for protein encapsulation and delivery , 2002 .

[66]  M. Woydt,et al.  In vivo droplet vaporization for occlusion therapy and phase aberration correction , 2002, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[67]  William F. Edmonds,et al.  Synthesis and self‐assembly of highly incompatible polybutadiene–poly(hexafluoropropylene oxide) diblock copolymers , 2005 .

[68]  K. Takeda,et al.  Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: Results at 2‐year mean follow up , 2007, International journal of urology : official journal of the Japanese Urological Association.

[69]  Alexander L. Klibanov,et al.  Microbubbles in ultrasound-triggered drug and gene delivery. , 2008, Advanced drug delivery reviews.

[70]  Y. Yonekawa,et al.  A new liquid material for embolization of arteriovenous malformations. , 1990, AJNR. American journal of neuroradiology.

[71]  Christoph A. Merten,et al.  Droplet-based microfluidic platforms for the encapsulation and screening of Mammalian cells and multicellular organisms. , 2008, Chemistry & biology.